SCHEMBL8780911

SCHEMBL8780911

CCCNCCCc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.82

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.59
KCNH2 Q12809 3/20 0.54
TSHR P16473 1/20 0.50
KCNJ1 P48048 2/20 0.48
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
S1PR2 O95136 1/20 0.46
S1PR4 O95977 1/20 0.46
S1PR1 P21453 1/20 0.46
S1PR3 Q99500 1/20 0.46
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
DRD3 P35462 1/20 0.46
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3118575 0.94 CHRM2 (0.59) CHRM2KCNH2TSHRKCNJ1ALDH1A1
SCHEMBL3122783 0.91 CHRM2 (0.65) CHRM2KCNH2TSHRALDH1A1S1PR2
SCHEMBL3116995 0.91 CHRM2 (0.65) CHRM2KCNH2TSHRALDH1A1S1PR2
SCHEMBL3124265 0.91 CHRM2 (0.65) CHRM2KCNH2TSHRALDH1A1S1PR2
SCHEMBL7939602 0.90 KCNH2 (0.63) CHRM2KCNH2TSHRKCNJ1ALDH1A1
SCHEMBL11238993 0.89 KCNH2 (0.63) CHRM2KCNH2TSHRALDH1A1MEN1
SCHEMBL8780821 0.89 CHRM2 (0.57) CHRM2KCNH2TSHRKCNJ1ALDH1A1
SCHEMBL11233919 0.88 KCNH2 (0.66) CHRM2KCNH2ALDH1A1S1PR2S1PR4
Hydrochloric Acid SCHEMBL11229997 0.88 KCNH2 (0.62) CHRM2KCNH2TSHRALDH1A1MEN1
SCHEMBL11235448 0.88 KCNH2 (0.66) CHRM2KCNH2ALDH1A1S1PR2S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102571-A1 SELECTIVE SIGMA-1 RECEPTOR LIGANDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-04-25 US disclosed
US-20130102571-A1 SELECTIVE SIGMA-1 RECEPTOR LIGANDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-04-25 US disclosed
EP-0697407-B1 Pyrimidinedione derivatives and antiarrhythmic compositions containing same MITSUI TOATSU CHEMICALS (JP) 1997-06-25 EP disclosed
EP-0697407-A1 Pyrimidinedione derivatives and antiarrhythmic compositions containing same MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-02-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102571-A1 SELECTIVE SIGMA-1 RECEPTOR LIGANDS SIGMAR1, OPRL1, OPRK1 CHRM2 167/4885KCNH2 2802/4885TSHR 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.